These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38460715)

  • 1. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
    Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE;
    J Hepatol; 2024 Aug; 81(2):227-237. PubMed ID: 38527524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
    Choi J; Choi GH; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Kim KM
    Liver Int; 2019 May; 39(5):985-994. PubMed ID: 30821090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
    Porta G; de Carvalho E; Santos JL; Gama J; Bezerra JA;
    J Pediatr; 2021 Feb; 229():95-101.e3. PubMed ID: 33500120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
    Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
    Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
    Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.
    Laschtowitz A; Zachou K; Lygoura V; Pape S; Derben F; Jaeckel E; Oller-Moreno S; Weidemann S; Krech T; Piecha F; Schön G; Liebhoff AM; Al Tarrah M; Heneghan M; Drenth JPH; Dalekos G; Taubert R; Lohse AW; Schramm C
    JHEP Rep; 2021 Aug; 3(4):100321. PubMed ID: 34381983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
    Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
    Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Ben Merabet Y; Barbe C; Heurgue-Berlot A; Thévenot T; Minello A; Habersetzer F; Samuel D; Bernard-Chabert B; Weil-Verhoeven D; Renard P; Clot H; Di Martino V; Louvet H; Bresson-Hadni S; Thiéfin G
    Dig Dis Sci; 2021 Jun; 66(6):2107-2117. PubMed ID: 32607807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
    Li YN; Ma H; Zhou L; Zhang J; Guo LP; Li SQ; Qian YQ; Wang BM
    Chin Med J (Engl); 2016 Oct; 129(20):2434-2440. PubMed ID: 27748335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
    Soares JC; Borgonovo A; Maggi DC; Pasinato AP; Ramos FG; Dantas-Corrêa EB; Schiavon LL; Narciso-Schiavon JL
    Minerva Gastroenterol Dietol; 2016 Jun; 62(2):138-47. PubMed ID: 27091035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH; Gearry RB; Frampton CM; Stedman CA
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
    Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
    Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M;
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.